Growing community of inventors

Weston, MA, United States of America

Alec C Kimmelman

Average Co-Inventor Count = 3.87

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 4

Alec C KimmelmanLewis C Cantley (3 patents)Alec C KimmelmanCostas A Lyssiotis (3 patents)Alec C KimmelmanJaekyoung Son (2 patents)Alec C KimmelmanRonald A DePinho (1 patent)Alec C KimmelmanJeffrey Wade Harper (1 patent)Alec C KimmelmanJoseph D Mancias (1 patent)Alec C KimmelmanHaoqiang Ying (1 patent)Alec C KimmelmanAlec C Kimmelman (4 patents)Lewis C CantleyLewis C Cantley (16 patents)Costas A LyssiotisCostas A Lyssiotis (8 patents)Jaekyoung SonJaekyoung Son (2 patents)Ronald A DePinhoRonald A DePinho (12 patents)Jeffrey Wade HarperJeffrey Wade Harper (4 patents)Joseph D ManciasJoseph D Mancias (1 patent)Haoqiang YingHaoqiang Ying (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Dana-farber-cancer Institute Inc. (4 from 1,210 patents)

2. Beth Israel Deaconess Medical Center, Inc. (4 from 517 patents)

3. Harvard College (1 from 2,968 patents)

4. The Brigham and Women's Hospital, Inc. (1 from 1,384 patents)


4 patents:

1. 10837015 - Targeting the glutamine to pyruvate pathway for treatment of oncogenic Kras-associated cancer

2. 10350264 - Compositions and methods for modulating NCOA4-mediated autophagic targeting of ferritin

3. 10138479 - Targeting the glutamine to pyruvate pathway for treatment of oncogenic Kras-associated cancer

4. 9745631 - Methods for diagnosing and treating oncogenic kras-associated cancer

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/3/2026
Loading…